Latest news and views from PBD Biotech about the detection, identification and eradication of tuberculosis and related mycobacterial diseases.
Loading...
April 24, 2024
Actiphage® TB, a novel phage-based diagnostic, is set to revolutionise the testing and treatment of tuberculosis.
Actiphage® TB, a novel phage-based diagnostic, is set to revolutionise the testing and treatment of tuberculosis.
April 24, 2024
Donated frozen PBMC samples will help accelerate development of new TB diagnostic.
Donated frozen PBMC samples will help accelerate development of new TB diagnostic.
April 3, 2024
We are delighted to announce that PBD Biotech has achieved ISO 13485 accreditation for the development and manufacture of diagnostic kits.
April 3, 2024
We are delighted to announce that PBD Biotech has achieved ISO 13485 accreditation for the development and manufacture of diagnostic...
March 22, 2024
World TB Day 2024 is a moment to take stock of developments in the fight to end tuberculosis; a treatable, preventable disease that is still the commonest cause of death from an infectious disease.
March 22, 2024
World TB Day 2024 is a moment to take stock of developments in the fight to end tuberculosis; a treatable,...
March 21, 2024
80 percent of people with tuberculosis (TB), the world’s most deadly infection, do not have a persistent cough and yet are still infective, according to a study led by Amsterdam UMC, published in the Lancet.
80 percent of people with tuberculosis (TB), the world’s most deadly infection, do not have a persistent cough and yet...
March 1, 2024
Dr Ben Swift says Actiphage could provide breakthrough test-of-cure for TB treatment.
Dr Ben Swift says Actiphage could provide breakthrough test-of-cure for TB treatment.
February 21, 2024
PBD Biotech is delighted to be shortlisted for the Bionow Social Impact award 2023. This Bionow Award recognises activities that address a pressing social challenge within the life sciences sector.
February 21, 2024
PBD Biotech is delighted to be shortlisted for the Bionow Social Impact award 2023. This Bionow Award recognises activities that...
January 23, 2024
A novel approach to studying the progression of tuberculosis (TB) from infection to disease has identified and treated people at increased risk of developing the disease that current methods of testing would not.
January 23, 2024
A novel approach to studying the progression of tuberculosis (TB) from infection to disease has identified and treated people at...
January 23, 2024
New paper in The Lancet Microbe shows Actiphage TB detects metabolically active M.tuberculosis in blood
New paper in The Lancet Microbe shows Actiphage TB detects metabolically active M.tuberculosis in blood
Thursday 8th February 2024
December 13, 2023
Dr Ben Swift, a pioneer in phage-based diagnostics, is to present in the 'What's in the Pipeline' session at BioInfect 2024.
Dr Ben Swift, a pioneer in phage-based diagnostics, is to present in the 'What's in the Pipeline' session at BioInfect...
November 23, 2023
Dr Ben Swift has been awarded a Horizon award by AMI for his ground-breaking work developing a phage-based diagnostic for tuberculosis.
November 23, 2023
Dr Ben Swift has been awarded a Horizon award by AMI for his ground-breaking work developing a phage-based diagnostic for...
November 14, 2023
Grant of a patent has been awarded to PBD Biotech for its Actiphage diagnostic for incipient tuberculosis in South Africa, this complements the regional West Africa patent gained earlier this year.
November 14, 2023
Grant of a patent has been awarded to PBD Biotech for its Actiphage diagnostic for incipient tuberculosis in South Africa, this complements...